Product Information
FIDAXOMICIN 200 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $90.5046 per EA under NDC 00480259634. Its NADAC has been published 46 times since Nov 19, 2025.
FDA first approved this application on Jan 16, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480259634
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FIDAXOMICINApproval Type
Generic (ANDA)
FDA Application
ANDA208443FDA Approved
1/16/2024
TE Code
AB
On Market Since
7/15/2025
Pharmacological Classes
Price Statistics
The NADAC for FIDAXOMICIN 200 MG TABLET has been published 46 times since Nov 19, 2025, and over the history we have for it it has declined 50.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $90.5046 per EA |
|---|---|
| All-time high | $193.6654 (Apr 15, 2026) |
| All-time low | $90.5046 (Sep 23, 2026) |
| 52-week high | $193.6654 |
| 52-week low | $90.5046 |
| Median price | $158.6579 |
| Average price | $148.7987 |
| Largest weekly change | -23.1% (Jun 17, 2026) |
| Weeks tracked | 46 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fidaxomicin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FIDAXOMICIN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FIDAXOMICIN 200 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $90.5046 per EA (NDC 00480259634), effective Sep 30, 2026.
How has the price of FIDAXOMICIN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for FIDAXOMICIN 200 MG TABLET has declined 50.5%. It has been tracked across 46 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for FIDAXOMICIN 200 MG TABLET?
Since Nov 19, 2025, the NADAC for FIDAXOMICIN 200 MG TABLET has ranged from a low of $90.5046 (Sep 23, 2026) to a high of $193.6654 (Apr 15, 2026), with a median of $158.6579 per EA.
Are there cheaper alternatives to FIDAXOMICIN 200 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FIDAXOMICIN 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FIDAXOMICIN 200 MG TABLET?
FIDAXOMICIN 200 MG TABLET (NDC 00480259634) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.